INS and type 2 diabetes mellitus: The explanation could be by the fact the C-peptide has a longer plasmatic half-life and it doesn’t go through hepatic extraction, thus showing better the pre-hepatic beta-cell insulin secretion, as highlighted for T2DM patients [44].